|Anthony Amaechi Attama is a professor of Pharmaceutics and the Director, Education Innovation Unit (Vice Chancellor’s Office) University of Nigeria, Nsukka. He is the Coordinator of Drug Delivery and Nanomedicines Research Group at the University of Nigeria. Prof. Attama was at the Institut für Pharmazeutische Technologie, Technische Universität Carolo-Wilhelmina zu Braunschweig, Germany for his postdoctoral research in pharmaceutical nanotechnology sponsored by Alexander von Humboldt Foundation, Germany. Prof. Attama was a Visiting Professor at the Laboratory of Membrane and Liposome Research, Department of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada (IMRIC), Hadassah Medical School, Hebrew University of Jerusalem, Israel (February to April 2018). He has researched extensively on lipid drug delivery systems- micro and nanomedicines using natural and biocompatible lipids. His research interests include among others, development and formulation of novel delivery systems (e.g. micro/nano systems) of bioactive agents for the control of tropical diseases. He collaborates with renowned scientists within and outside Nigeria. Prof. Attama has won many research and travel grants, and has attended many scientific conferences and workshops. He supervises postgraduate students in pharmaceutical sciences and has many research articles published in peer-reviewed high impact journals. In a bid to translate research results to products, he has fostered the establishment of some pharmaceutical industries in Nigeria and also serves as a consultant to many pharmaceutical companies. Prof. Attama is a registered pharmacist and a Federal Government licenced drug analyst.